Company overview unavailable
$223.55
+$14.72 (+7.05%)Last close · 2026-09-04
Free AI rating for MRVL
See QuantAdvisor's buy/sell/hold call and the reasoning — no account needed.
Price history
Daily closing prices for MRVL.
-$65.30 (-22.61%) over the last 3m
Related news
Recent coverage of MRVL.

Nvidia rose only 0.8% on September 4, while Astera Labs jumped 9.8% and Marvell gained 7.1%. The comparison was consistent with investors broadening the AI trade beyond accelerators into connectivity suppliers. Astera’s rally also coincided with speculation that the company could be added to the S&P 500, although it was ultimately not selected in the […]
Yahoo · 23h ago

A number of stocks jumped in the afternoon session after investors shrugged off interest rate hike expectations following the August jobs report and unwound defensive positioning in beaten-down chip designers, according to Bloomberg. The U.S. Bureau of Labor Statistics reported that employers added 162,000 nonfarm payroll jobs in August, easily beating estimates of a 56,000 increase from economists polled by FactSet. The agency also reported that the national unemployment rate held steady at 4.1
Yahoo · 1d ago

Marvell raised its annual forecasts on August 27, yet its shares fell as investors focused on the timing of revenue from a custom AI-chip relationship with Google. Management said material Google revenue was not expected until fiscal 2029, even though its outlook already included some contribution and the longer opportunity could be substantial. Marvell Technology, […]
Yahoo · 1d ago

Marvell Technology (MRVL) stock returned 235.9% over the past year, climbing from $62.18 to $208.83. The company kept raising what it expects to sell, and buyers repriced it each time. Then the shares pulled back, and they now sit well below their best.
Yahoo · 1d ago

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.
ChartMill · 1d ago

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg.
Yahoo · 2d ago

The chipmaker got a lift from a sizable acquisition in the AI space.
Yahoo · 2d ago

The AI trade is bucking the trend Friday.
Yahoo · 2d ago
Key statistics
Company fundamentals are temporarily unavailable.
StockTwits chatter
What traders are saying on StockTwits right now
No StockTwits chatter available right now.
Source: StockTwits
Community
Recent posts mentioning MRVL.
Sign in to join the QuantAdvisor conversation on MRVL — post your take, like and follow.
Data may be delayed. For research, not financial advice.
© 2026 QuantAdvisor. All rights reserved.